Investigation Report on Undeclared Ingredients in UK COVID-19 Vaccines.

This report, conducted by the UNIT unit at the request of EbMC2 CiC, presents the initial findings of a qualitative analysis regarding the contents of four vaccine vials (Moderna x2, AstraZeneca x1, and Pfizer x1) used in the United Kingdom. The primary objective of the study was to identify undeclared ingredients—specifically graphene-related compounds, parasites, and biological filaments—following reports of numerous adverse reactions and deaths.

Key points of the report:

  • Graphene Confirmation: Microscopy and Raman spectroscopy analyses confirmed the presence of graphene compounds in all four investigated vials.
  • Identification of Inclusions: Various types of inclusions were detected, including:
    • Graphene nanoribbons coated with polyethylene glycol (PEG).
    • Graphene composite forms (Forms 1 and 2).
    • Microcrystalline calcite with carbonaceous inclusions.
    • Graphene nanoforms, such as scrolls and spherical objects.
  • Results by Brand:
    • In AstraZeneca, the movement and self-assembly of nanoparticles were observed, with direct confirmation of graphene in all identified forms.
    • In Moderna and Pfizer, similar structures were found, such as transparent sheets of graphene compounds and fibrous ribbons.
  • Methodology: The study utilized advanced optical and petrological microscopy techniques, as well as Raman spectroscopy for the chemical identification of carbon compounds.
  • Toxicity Concerns: The document includes a literature review on the toxicity of Graphene Family Nanoparticles (GFNs), noting that they can induce acute inflammatory responses, chronic tissue injury, and cross physiological barriers such as the blood-air barrier or the placenta.

The report concludes that the presence of these undeclared materials requires urgent additional investigation to determine their exact concentration and long-term effects on human health.

UK LAB REPORT BY ‘UNIT’Descarga

Entradas relacionadas